Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
Why publish in npj Vaccines?
- Dedicated to research and development of human and veterinary vaccines.
- Independence & quality through strong collaboration between external and internal editors.
- Progressive & modern: value for researchers through open-access and publishing innovation.
Find out futher information on the journal aims and scope here.
Please see the detailed outline of the content types that npj Vaccines considers.
npj Vaccines is a fully open access journal. More on Creative Commons Attribution licenses and the benefits of publishing open access can be found in this section.
To allow immediate global open access to all articles, npj Vaccines levies an article processing charge (APC). Current APCs and waiver information are available in this section.
Find out about journal metrics and up-to-date abstracting and indexing information for npj Vaccines here.
npj Vaccines is a high-quality Nature Portfolio journal published by Springer Nature in partnership with the Sealy Institute for Vaccine Sciences – find out more.